A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07903857

Title field or adapter rule

{'original_value': 'A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:28.794863+00:00

Published At

2026-10-29T00:00:00+00:00

Record Updated At

2026-10-29

Source Retrieved At

2026-10-31T22:18:28.651351+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Colorectal Neoplasms", "Stomach Neoplasms", "Solid Tumor Malignancies"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07903857"

protocolSection.identificationModule.officialTitle

"A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Colorectal Neoplasms (protocolSection.conditionsModule.conditions)
• Stomach Neoplasms (protocolSection.conditionsModule.conditions)
• Solid Tumor Malignancies (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['SND002 Cell Injection'], 'description': "SND002 Cell Injection is an autologous cell therapy product derived from the participant's own T lymphocytes. The cells are obtained from a fresh tumor-draining lymph node collected during surgery, expanded in vitro, and formulated for intravenous administration. Each participant receives a single intravenous infusion on Day 0. The dose is defined by the number of cells administered and is selected from three planned cell-dose ranges in the dose-escalation part of the study. No allogeneic or off-the-shelf product is used; each preparation is manufactured from, and administered to, the same individual.", 'name': 'SND002 Cell Injection', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.